Medical oncologists administer anticancer drug regorafenib to try to improve overall survival in patients with metastatic colorectal cancer who have ceased to respond to standard therapy (known as refractory mCRC). However, ...
Jul 6, 2019
0
0
A targeted cancer drug will now be available for some adults with advanced liver cancer on the NHS.
Nov 30, 2018
0
1
An international phase 3 trial has found that the drug regorafenib improved survival in patients with advanced hepatocellular carcinoma (HCC), a form of liver cancer, giving people who previously had no other options a better ...
Jan 18, 2017
0
121
Regorafenib (trade name: Stivarga) has been approved in Germany since August 2013 for adults with metastatic colorectal cancer in whom previous treatments are no longer effective or for whom these alternatives are not an ...
Jan 10, 2014
0
0
